Challenges of big data integration in the life sciences.


Journal

Analytical and bioanalytical chemistry
ISSN: 1618-2650
Titre abrégé: Anal Bioanal Chem
Pays: Germany
ID NLM: 101134327

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 21 05 2019
accepted: 06 08 2019
revised: 08 07 2019
pubmed: 30 8 2019
medline: 28 11 2019
entrez: 30 8 2019
Statut: ppublish

Résumé

Big data has been reported to be revolutionizing many areas of life, including science. It summarizes data that is unprecedentedly large, rapidly generated, heterogeneous, and hard to accurately interpret. This availability has also brought new challenges: How to properly annotate data to make it searchable? What are the legal and ethical hurdles when sharing data? How to store data securely, preventing loss and corruption? The life sciences are not the only disciplines that must align themselves with big data requirements to keep up with the latest developments. The large hadron collider, for instance, generates research data at a pace beyond any current biomedical research center. There are three recent major coinciding events that explain the emergence of big data in the context of research: the technological revolution for data generation, the development of tools for data analysis, and a conceptual change towards open science and data. The true potential of big data lies in pattern discovery in large datasets, as well as the formulation of new models and hypotheses. Confirmation of the existence of the Higgs boson, for instance, is one of the most recent triumphs of big data analysis in physics. Digital representations of biological systems have become more comprehensive. This, in combination with advances in machine learning, creates exciting new research possibilities. In this paper, we review the state of big data in bioanalytical research and provide an overview of the guidelines for its proper usage.

Identifiants

pubmed: 31463515
doi: 10.1007/s00216-019-02074-9
pii: 10.1007/s00216-019-02074-9
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

6791-6800

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : Project INF, SFB/TR 209 "Liver Cancer".

Auteurs

Sven Fillinger (S)

Quantitative Biology Center (QBiC), University of Tübingen, Auf der Morgenstelle 10, 72076, Tübingen, Germany.

Luis de la Garza (L)

Quantitative Biology Center (QBiC), University of Tübingen, Auf der Morgenstelle 10, 72076, Tübingen, Germany.

Alexander Peltzer (A)

Quantitative Biology Center (QBiC), University of Tübingen, Auf der Morgenstelle 10, 72076, Tübingen, Germany.

Oliver Kohlbacher (O)

Center for Bioinformatics, University of Tübingen, 72076, Tübingen, Germany.
Applied Bioinformatics, Department of Computer Science, 72076, Tübingen, Germany.
Institute for Translational Bioinformatics, University Hospital of Tübingen, 71016, Tübingen, Germany.
Biomolecular Interactions, Max Planck Institute for Developmental Biology, 72076, Tübingen, Germany.

Sven Nahnsen (S)

Quantitative Biology Center (QBiC), University of Tübingen, Auf der Morgenstelle 10, 72076, Tübingen, Germany. sven.nahnsen@uni-tuebingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH